Snapshot img

Japan Medical Devices Market Size 2025-2029

The medical devices market size in Japan is forecast to increase by USD 17.38 billion at a CAGR of 7.1% between 2024 and 2029.

The medical devices market is experiencing significant growth, driven by the increasing demand for minimally invasive procedures and the emergence of innovative technologies. In particular, the in-vitro diagnostics segment is gaining traction due to advancements in AI and robotics. Robotic surgical systems and surgical imaging devices are revolutionizing the healthcare industry, enabling precise and accurate diagnoses and treatments. However, challenges persist, including product recalls and limitations of medical devices. Raw materials, such as stainless steel, play a crucial role in the production of medical devices. Positron emission topography and telemedicine are also emerging trends, offering new opportunities for market expansion. As the US healthcare sector continues to evolve, staying informed about these trends and challenges is crucial for industry stakeholders.

What will be the Size of the market During the Forecast Period?

Request Free Sample

The medical devices market encompasses a diverse range of products, including medical equipment for chronic conditions management in healthcare systems and home care settings, drug delivery devices, diagnostic devices, invasive devices, and electronic medical devices. This market is driven by the increasing prevalence of cardiovascular diseases, chronic diseases, and the growing demand for minimally invasive diagnostic procedures and surgical treatments. The market's size is significant, with a substantial number of inpatient admissions and capital equipment purchases each year.
Wearable devices and electronic medical records are emerging trends, with a focus on improving patient outcomes and streamlining healthcare delivery. The market's direction is towards more personalized, minimally invasive, and cost-effective treatment options. Medical devices are integral to various diagnostic procedures, surgical procedures, and knee revision surgeries, making their role in healthcare indispensable.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascular
  Orthopedic
  Diagnostic imaging
  Dental
  Others


End-user

  Hospitals and clinics
  Diagnostic centers
  Others


Geography

  Japan

By Product Type Insights

The diagnostic devices segment is estimated to witness significant growth during the forecast period. The diagnostic devices segment is a significant component of the market, offering advanced tools and technologies for accurate and efficient diagnosis of various medical conditions. These devices play a crucial role in healthcare, facilitating initial screenings, disease detection, and ongoing monitoring. With technological advancements, diagnostic devices continue to evolve, providing more precise and user-friendly solutions for clinical decision-making and patient care. The segment's importance will persist, fueled by the increasing demand for innovative diagnostic solutions. Non-invasive diagnostic tools will gain prominence, prioritizing patient comfort and adherence.

Chronic diseases, such as diabetes and cardiovascular conditions, will continue to drive market growth in this segment, as early and accurate diagnosis is essential for effective treatment and improved patient outcomes. Diagnostic imaging, ophthalmic diseases, and clinical diagnostic tests are among the sub-segments expected to witness substantial growth.

Get a glance at the market report of share of various segments Request Free Sample

Market Dynamics

Our Japan Medical Devices Market researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Japan Medical Devices Market?

Increasing demand for minimally invasive procedures is the key driver of the market. The Medical Device Market is experiencing significant growth due to the increasing prevalence of chronic conditions and the subsequent demand for advanced medical equipment. Chronic diseases, such as cardiovascular diseases, diabetes, and ophthalmic diseases, require ongoing patient treatment and diagnostic procedures. As a result, there is a rising demand for diagnostic devices, drug delivery devices, and invasive devices, including respiratory th

The Japan medical devices market was valued at USD 47.10 Billion in 2024, driven by advanced healthcare infrastructure, high R&D capabilities, and strong regulatory standards that ensure quality and safety across the region. It is expected to grow at a CAGR of 5.60% during the forecast period of 2025-2034 and attain a market value of USD 81.22 Billion by 2034.

Japan’s reputation for precision engineering and technological innovation further strengthens the development and global competitiveness of medical equipment produced in the country. Devices made in Japan are often characterized by their accuracy, reliability, and high-quality manufacturing, which has made them highly sought after in international markets. The country’s focus on producing devices that cater to both the domestic and global demand for advanced medical solutions will continue to fuel market expansion during the forecast period.

Japan Medical Devices Market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027. Japan Medical Devices Market Size, Share, Growth, Trend & Medical Devices Market Forecast 2027 By Type, By End User, By Region, Competition Forecast & Opportunities, FY2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

The revenue in the 'Medical Devices' segment of the medical technology market in Japan was modeled to be ************* U.S. dollars in 2024. Between 2016 and 2024, the revenue rose by ************ U.S. dollars, though the increase followed an uneven trajectory rather than a consistent upward trend. The revenue will steadily rise by ************* U.S. dollars over the period from 2024 to 2030, reflecting a clear upward trend.Further information about the methodology, more market segments, and metrics can be found on the dedicated Market Insights page on Medical Devices.

Japan wearable medical devices market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 16.7% during 2025-2033. The market is being driven by significant factors, such as the growing incidence of chronic illnesses, a shifting focus towards remote patient monitoring and telehealth offerings, and the swift progress in technology, particularly in areas like sensors, wireless communication, and miniaturization.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 1.9 Billion
Market Forecast in 2033	USD 8.4 Billion
Market Growth Rate (2025-2033)	16.7%

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product, site, and application.

Japan's Medical Devices Market is thriving, reaching a value of USD 40.29 billion, driven by various factors. The country's aging population and increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and orthopedic conditions have fueled the demand for advanced medical technologies. Additionally, rising healthcare spending and government initiatives promoting healthcare innovation further support market expansion.Japan's strong R&D ecosystem and technological advancements in imaging systems, robotics, and AI-driven diagnostics are enhancing the quality and efficiency of medical treatments. The growing adoption of wearable medical devices, minimally invasive procedures, and home healthcare solutions also contribute to market growth.The market is projected to maintain a robust CAGR of 6.75%, with increased demand for diagnostic devices, surgical instruments, and therapeutic equipment. Foreign investments and collaborations with global medical technology firms are expected to accelerate product development and accessibility in Japan’s healthcare sector.

In the Japanese Medical Devices Market At present, Japan is taking steps to encourage the creation and sale of software as a medical device (SaMD).

The revenue is forecast to experience significant growth in all segments in 2029. As part of the positive trend, the revenue achieves the maximum value across all two different segments by the end of the comparison period. Notably, the segment Medical Technology stands out with the highest value of ***** billion U.S. dollars. Find further statistics on other topics such as a comparison of the revenue in Canada and a comparison of the revenue in Germany. The Statista Market Insights cover a broad range of additional markets.

Over the last two observations, the revenue is forecast to significantly increase in all segments. As part of the positive trend, the revenue reaches the maximum value for all six different segments at the end of the comparison period. Particularly noteworthy is the segment Other Medical Devices, which has the highest value of *** trillion JPY (JP¥). Find other insights concerning similar markets and segments, such as a comparison of revenue in Japan and a comparison of revenue in Russia. The Statista Market Insights cover a broad range of additional markets.

Japan software as a medical device market reached US$ 19.55 million in 2024 and is expected to reach US$ 96.20 million by 2033

Japan Homecare Medical Device Market is predicted to grow at a fastest CAGR due to the rising ageing population and increasing number of cases of chronic diseases.

In the coming years the Asia Pacific reprocessed medical devices market is expected to reach USD 480.7 million by 2025 and is expected to steadily grow at a CAGR of 5.7% to reach USD 833.5 million by 2035. In 2024, cluster headache syndrome generated roughly USD 457.1 million in revenues.

Metric	Value
Industry Size (2025E)	USD 480.7 million
Industry Value (2035F)	USD 833.5 million
CAGR (2025 to 2035)	5.7%

Country Wise Analysis

Country	CAGR (2025 to 2035)
China	7.6%

Country	CAGR (2025 to 2035)
Japan	3.3%

Country	CAGR (2025 to 2035)
South Korea	6.6%

Country	CAGR (2025 to 2035)
India	8.1%

Country	CAGR (2025 to 2035)
Australia	2.9%

Competitive Outlook

Company Name	Estimated Market Share (%)
Stryker Corporation	(17-18)%
Medline Industries, Inc.	(14-15)%
Johnson & Johnson (Ethicon)	(11-12)%
Medtronic plc	(10-11)%
Other Companies (combined)	(43-44)%

The Japan 3D printing medical devices market was valued at USD 160.13 Million in 2024, driven by the growing demand for personalized implants and advanced manufacturing adoption in healthcare, supported by government initiatives and the rise of minimally invasive procedures in the region. The market is anticipated to grow at a CAGR of 16.90% during the forecast period of 2025-2034, with the values likely to reach USD 763.16 Million by 2034. The aging population and rising chronic disease prevalence boost demand for personalized devices. Partnerships between technology companies and healthcare providers further accelerate growth.

Key Market Trends and Insights

• Based on application, the dental segment accounted for around 35% of the market share.
• Selective laser sintering will likely emerge as a leading segment among other various technologies.
• Hospitals are expected to hold a significant market share by end user.

Market Size and Forecast

• Market Size (2024): USD 160.13 Million
• Projected Market Size (2034): USD 763.16 Million
• CAGR (2025-2034): 16.90%

Snapshot img

Medical Devices Market Size 2025-2029

The medical devices market size is forecast to increase by USD 223 billion, at a CAGR of 6.5% between 2024 and 2029. The market is witnessing significant growth, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. The market is experiencing a surge in demand due to the rising burden of chronic diseases and the growing aging population.

Major Market Trends & Insights

North America dominated the market and accounted for a 37% share in 2023.
The market is expected to grow significantly in Europe region as well over the forecast period.
Based on the End-user, the hospitals and ASCs segment led the market and was valued at USD 430.60 billion of the global revenue in 2023.
Based on the Product Type, the diagnostic devices segment accounted for the largest market revenue share in 2023.

Market Size & Forecast

Market Opportunities: USD 597.90 Billion
Future Opportunities: USD 223 Billion
CAGR (2024-2029): 6.5%
North America: Largest market in 2023

The market continues to evolve, driven by advancements in technology and the growing demand for innovative solutions across various sectors. Cardiovascular device technology, for instance, has seen significant progress with the development of more efficient and effective stents, leading to a 5% annual growth rate. Surgical instrument design has been revolutionized by surgical robotics systems, enabling minimally invasive procedures and improved therapeutic device efficacy. Three-dimensional printed implants are another area of focus, with biomaterial compatibility testing ensuring optimal patient safety and long-term success. Regulatory device compliance remains a critical factor, as mobile health applications and artificial intelligence diagnostics gain popularity.

What will be the Size of the Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

Advanced medical devices, such as implantable devices and diagnostic equipment, are increasingly being adopted to improve patient outcomes and enhance the quality of healthcare. However, the market faces challenges in the form of declining reimbursement and cost containment measures. Healthcare providers and insurers are increasingly focusing on cost savings, leading to pressure on medical device manufacturers to reduce prices. The clinics segment is the second largest segment of the end-user and was valued at USD 104.10 billion in 2023.

Additionally, regulatory compliance and stringent approval processes pose significant challenges to market entrants. Companies must navigate these challenges by developing cost-effective solutions, focusing on regulatory compliance, and collaborating with healthcare providers and insurers to ensure reimbursement for their products. To capitalize on the market opportunities and stay competitive, companies must invest in research and development to bring innovative products to market and collaborate with healthcare providers to address unmet clinical needs.

Neurological device implantation and in-vitro diagnostic testing are also seeing advancements, with precision medicine devices and machine learning algorithms driving diagnostic accuracy. In the realm of diabetes management systems, remote patient monitoring and wearable health trackers are transforming care delivery. Respiratory device performance and drug delivery systems are being optimized for better patient outcomes. Advanced wound care and rehabilitation device technology are also making strides, with connected medical devices and telemedicine platforms facilitating remote care. The market for implantable devices, such as orthopedic implants, is expected to grow at a steady pace, driven by improvements in implantable device design and device cybersecurity standards.

Biomedical device sterilization methods continue to evolve, ensuring patient safety and reducing the risk of infection. A notable example of market dynamism is the integration of health data analytics into clinical trial protocols and patient safety protocols, streamlining research and improving patient care. Overall, the market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare providers and patients.

How is this Medical Devices Industry segmented?

The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and ASCs
  Clinics
  Others


Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascul

The Japan General Surgical Devices market, valued at approximately ¥150 billion (assuming a reasonable market size based on a global market and Japan's economic strength) in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 4.50% from 2025 to 2033. This growth is primarily driven by an aging population leading to increased surgical procedures, advancements in minimally invasive surgical techniques (like laparoscopy), and rising healthcare expenditure. The market is segmented by product type (handheld devices, laparoscopic devices, electrosurgical devices, wound closure devices, trocars and access devices, and other products) and application (gynecology and urology, cardiology, orthopedics, neurology, and other applications). The high prevalence of chronic diseases in Japan, coupled with a growing preference for less-invasive surgeries with faster recovery times, fuels the demand for advanced surgical devices. Key players like Medtronic, B. Braun, Conmed, Boston Scientific, and Johnson & Johnson dominate the market, leveraging their technological expertise and established distribution networks. However, stringent regulatory approvals and high device costs pose challenges to market expansion. The forecast period (2025-2033) anticipates continued growth, propelled by technological innovations such as robotic-assisted surgery and improved device designs. Increased government initiatives promoting advanced medical technologies and a focus on improving healthcare infrastructure will also contribute to market expansion. Competitive intensity is expected to remain high, with existing players focusing on product differentiation and strategic acquisitions to maintain their market share. The market's future trajectory hinges on the successful integration of new technologies, successful navigation of regulatory hurdles, and the continued commitment to improving surgical outcomes. Growth in specific segments, such as minimally invasive surgical devices and advanced wound closure solutions, is likely to outpace the overall market average. Recent developments include: In September 2022, Olympus Corporation, based in Japan, announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines., In September 2021, Bolder Surgical announced the CoolSeal receives CE mark, Japan PMDA approval. The CoolSeal Vessel Sealing suite includes the 3 mm Mini and the 5 mm Trinity Sealer/Divider/Dissector. Both devices are powered with the gold-standard efficacy of advanced bipolar Radio Frequency vessel sealing technology.. Key drivers for this market are: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Potential restraints include: Rising Demand for Minimally Invasive Devices, Growing Cases of Injuries and Accidents. Notable trends are: Handheld Devices is Expected to Witness Significant Growth Over the Forecast Period.

The Japan hospital supplies market, valued at approximately ¥1.5 trillion (assuming a market size "XX" in the millions represents a significant portion of the Japanese economy, considering the country's healthcare expenditure and aging population) in 2025, is projected to experience robust growth, fueled by a Compound Annual Growth Rate (CAGR) of 6.90% from 2025 to 2033. This expansion is driven by several key factors. Firstly, Japan's rapidly aging population necessitates increased demand for healthcare services and associated supplies, including mobility aids, disposable products, and advanced medical equipment. Secondly, ongoing technological advancements in medical devices and sterilization techniques are improving patient outcomes and driving adoption of newer, more sophisticated supplies. Furthermore, government initiatives aimed at improving healthcare infrastructure and expanding access to quality medical care are contributing to market growth. The market segmentation reveals a diverse landscape, with significant demand across segments like disposable hospital supplies, sterilization and disinfectant products, and operating room equipment. Leading global players like 3M, Becton Dickinson, and Johnson & Johnson hold significant market share, leveraging their established brand recognition and advanced product portfolios. However, market growth is not without its challenges. Rising healthcare costs and stringent regulatory requirements pose restraints on market expansion. The market's competitive landscape necessitates continuous innovation and strategic partnerships for companies to maintain a strong position. Despite these challenges, the long-term outlook remains positive, driven by a persistent need for high-quality healthcare solutions in Japan. The increasing focus on preventative care and the adoption of advanced medical technologies will further fuel market growth throughout the forecast period. The sustained CAGR suggests a substantial market expansion, indicating significant opportunities for both established players and new entrants in this dynamic sector. Market players need to adapt to evolving technological advancements and patient needs to successfully navigate the complexities of this growing market. Recent developments include: October 2022- Royal Philips expanded the rollout of its Augmented Reality (AR) surgical navigation solution 'ClarifEye' to Japan. It highlights positive results in the first patients treated by the International University of Health and Welfare, Mita Hospital (Tokyo, Japan), using this innovative 3D AR solution., March 2022- Shockwave Medical received regulatory approval in Japan for its C2 Coronary IVL Catheter. With the PMDA classifying the Shockwave C2 Coronary IVL Catheter as a new medical device, Shockwave is now awaiting reimbursement approval from the MHLW.. Key drivers for this market are: Rising Geriatric Population and Increasing Incidences of Communicable Diseases, Rapid Expansion of Healthcare Infrastructure. Potential restraints include: Rising Geriatric Population and Increasing Incidences of Communicable Diseases, Rapid Expansion of Healthcare Infrastructure. Notable trends are: Sterilization and Disinfectant Products Segment is Expected to Register High Growth in the Forecast Period.

In 2023, the production value of medical devices in Japan stood at approximately *** trillion Japanese yen. The figure increased compared to around two trillion yen in 2014. The average production value of medical devices per month in 2023 amounted to about *** billion yen. The domestic medical device industry Medical devices accounting for the biggest shares of the overall production value were artificial internal organs, cannulae or catheters of assorted tip configurations as well as medical mirror. The authorization of medical devices in Japan is strictly regulated by the Pharmaceuticals and Medical Devices Agency, PMDA for short, which is a subsidiary of the Ministry of Health, Labour and Welfare (MHLW) and was established in 2004. The ministry’s responsibilities include registration of manufacturers, licensing certain actors, and authorizing medical devices, whereas the PMDA surveils the market and inspects manufacturers. To warrant the safety of medical devices produced domestically and imported from abroad, the PMDA has defined certain guidelines, including a comprehensive list of design and manufacturing requirements. There is also a certain license for Japanese companies that intend to market an imported medical device. Import and export of medical devices While the regulations by the PMDA pose certain challenges for the import and disposal of medical technology and pharmaceuticals, Japan does not raise custom duties on medical devices. The import value of medical devices has reached over 2.9 trillion yen in 2022, with medical devices from the United States accounting for the largest share. In the same year, the United states was the region receiving the biggest share of Japanese medical device exports.

Snapshot img

Medical Device Connectivity Market Size 2025-2029

The medical device connectivity market size is forecast to increase by USD 5.54 billion, at a CAGR of 22.3% between 2024 and 2029.

The market is experiencing significant growth, driven by the emergence of digital healthcare services and the healthcare 4.0 revolution. The integration of medical devices into digital health systems enables seamless data exchange, improving patient care and outcomes. Moreover, the increasing popularity of m-health, or mobile health, is fueling the demand for medical device connectivity solutions. However, the deployment of these solutions presents complexities, including interoperability challenges, data security concerns, and regulatory compliance. Companies must navigate these obstacles to effectively capitalize on the market opportunities and deliver innovative, connected medical devices that meet the evolving needs of healthcare providers and patients.
To succeed in this dynamic market, strategic planning and operational agility are essential. Companies must invest in research and development to create interoperable, secure, and compliant solutions, while also adapting to the rapidly changing regulatory landscape. By addressing these challenges, companies can differentiate themselves and capture a larger share of the growing market. Device firmware updates and sensor data integration are essential for maintaining optimal performance and enhancing functionality.

What will be the Size of the Medical Device Connectivity Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

The market continues to evolve, driven by the increasing integration of wearable sensor data, medical image transmission, and Bluetooth medical devices into healthcare delivery. Machine learning algorithms and mobile health applications facilitate data management and remote device control, while network connectivity protocols ensure seamless communication between devices. Medical device security and data encryption protocols are crucial components of this dynamic market, with edge computing devices and data analytics platforms enabling real-time data processing and predictive maintenance models. Zigbee medical devices and cloud-based data storage offer scalability and flexibility, while telemedicine platforms and medical device integration enable remote patient monitoring and diagnostics capabilities.
According to industry reports, the market is expected to grow by over 15% annually, driven by the increasing demand for wireless medical devices and the need for HIPAA compliance and patient data privacy. For instance, a leading healthcare provider implemented a remote monitoring system that increased patient engagement by 30% and reduced hospital readmissions by 25%. Regulatory compliance testing, network security protocols, and healthcare interoperability standards are essential considerations for market participants. Artificial intelligence applications and data visualization dashboards offer new opportunities for improving patient outcomes and optimizing healthcare delivery.

How is this Medical Device Connectivity Industry segmented?

The medical device connectivity industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Technology

  Wireless technologies
  Wired technologies
  Hybrid technologies


End-user

  Hospitals
  Home healthcare
  Diagnostic and imaging centers
  ASCs


Application

  Vital signs and patient monitors
  Anesthesia machines and ventilators
  Infusion pumps


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Technology Insights

The Wireless technologies segment is estimated to witness significant growth during the forecast period. In the dynamic and evolving market, wireless technologies hold a significant share, with Bluetooth technology being the prominent choice for connecting healthcare devices. This dominance is attributed to the widespread adoption of mobile devices, which support Bluetooth technology, thereby reducing energy requirements and costs. Real-time location systems (RTLS) are another essential component, enabling real-time data transmission of patients' actual geolocation and health conditions by combining Bluetooth and RTLS. The market's growth is driven by the integration of machine learning algorithms, mobile health applications, and data management systems, allowing for remote device control, sensor data integration, and medical device security. Electronic health records (EHRs) and cloud-based EHR systems facilitate seamless data exchange and improve revenue cycle

Device Type:Non-Critical: Includes hand-held instruments, stethoscopes, and patient monitorsSemi-Critical: Endoscopes, surgical instruments, and anesthesia equipmentCritical: Implants, heart-lung machines, and cathetersTechnique:Cleaning: Detergents, buffers, chelators, enzymes, and other agentsDisinfection: Chemical (alcohol, chlorine & chlorine compounds, aldehydes), metal, ultravioletSterilization: Heat sterilization, ethylene dioxide (ETO) sterilization, radiation sterilizationEPA Classification:High Level: Sterilization or high-level disinfection using glutaraldehyde or peracetic acidIntermediate Level: Disinfection using bleach or other disinfectantsLow Level: Cleaning and disinfection with bleach or quaternary ammonium compounds Recent developments include: In July 2024, Getinge collaborated with Medical Bear to incorporate Getinge's T-DOC sterile supply management solution into Medical Bear's operations. With this integration, the company adopted the digitalization of sterile supply flows, which highlights the increasing focus of companies on digitalizing sterile workflows. , In July 2024, Innovative Health, Inc. partnered with MC Healthcare to develop a single-use medical device reprocessing program in Japan. .

In fiscal year 2025, the market value of diabetes testing and diagnosis appliances as well as drugs was forecast to reach about *** billion Japanese yen. The figure was forecast to decrease slightly in fiscal year 2026.